Unknown

Dataset Information

0

Expression and characterization of recombinant IL-1Ra in Aspergillus oryzae as a system.


ABSTRACT:

Background

The interleukin-1 receptor antagonist (IL-1Ra) is a crucial molecule that counteracts the effects of interleukin-1 (IL-1) by binding to its receptor. A high concentration of IL-1Ra is required for complete inhibition of IL-1 activity. However, the currently available Escherichia coli-expressed IL-1Ra (E. coli IL-1Ra, Anakinra) has a limited half-life. This study aims to produce a cost-effective, functional IL-1Ra on an industrial scale by expressing it in the pyrG auxotroph Aspergillus oryzae.

Results

We purified A. oryzae-expressed IL-1Ra (Asp. IL-1Ra) using ion exchange and size exclusion chromatography (53 mg/L). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis revealed that Asp. IL-1Ra is N-glycosylated and approximately 17 kDa in size. We conducted a comparative study of the bioactivity, binding kinetics, and half-life between Asp. IL-1Ra and E. coli IL-1Ra. Asp. IL-1Ra showed good bioactivity even at a low concentration of 0.5 nM. The in vitro half-life of Asp. IL-1Ra was determined for different time points (0, 24, 48, 72, and 96 h) and showed higher stability than E. coli IL-1Ra, despite exhibiting a 100-fold lower binding affinity (2 nM).

Conclusion

This study reports the production of a functional Asp. IL-1Ra with advantageous stability, without extensive downstream processing. To our knowledge, this is the first report of a recombinant functional and stable IL-1Ra expressed in A. oryzae. Our results suggest that Asp. IL-1Ra has potential for industrial-scale production as a cost-effective alternative to E. coli IL-1Ra.

SUBMITTER: Mahmoudi Azar L 

PROVIDER: S-EPMC10283290 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Expression and characterization of recombinant IL-1Ra in Aspergillus oryzae as a system.

Mahmoudi Azar Lena L   Karaman Elif E   Beyaz Burcu B   Göktan Işılay I   Eyüpoğlu Alp Ertunga AE   Kizilel Seda S   Erman Batu B   Gül Ahmet A   Uysal Serdar S  

BMC biotechnology 20230620 1


<h4>Background</h4>The interleukin-1 receptor antagonist (IL-1Ra) is a crucial molecule that counteracts the effects of interleukin-1 (IL-1) by binding to its receptor. A high concentration of IL-1Ra is required for complete inhibition of IL-1 activity. However, the currently available Escherichia coli-expressed IL-1Ra (E. coli IL-1Ra, Anakinra) has a limited half-life. This study aims to produce a cost-effective, functional IL-1Ra on an industrial scale by expressing it in the pyrG auxotroph As  ...[more]

Similar Datasets

| S-EPMC2012976 | biostudies-other
| S-EPMC2773364 | biostudies-literature
| S-EPMC9290255 | biostudies-literature
| S-EPMC4230903 | biostudies-literature
| S-EPMC1220194 | biostudies-other
| S-EPMC6863284 | biostudies-literature
| S-EPMC4048174 | biostudies-literature
| S-EPMC8484427 | biostudies-literature
| S-EPMC4161032 | biostudies-literature
| S-EPMC4086290 | biostudies-literature